Frost & Sullivan Recognizes GenePOC's Growth Backed By Strong Leadership And Technology Excellence
The GenePOC system's protocols are the same for all tests, even for those with different targets and different samples. Moreover, the volume capacity of GenePOC's system exceeds that of other systems.
Unlike other systems, GenePOC's system does not produce significant amounts of waste; it produces approximately 10 percent of the waste of other devices, in terms of both volume and weight. As the system does not require purification and amplification of sample DNA, it offers enhanced ease of use and efficiency.
"GenePOC aims to transform the market by responding to customers' demand for a simple, user-friendly molecular diagnostic system," noted Brice. "It continues to find ways to improve its methods in order to produce affordable and, therefore, viable molecular diagnostic test consumables."
Each year, Frost & Sullivan presents this award to the company that has demonstrated entrepreneurial spirit by devising a strong growth strategy and robustly implementing it. The recipient has shown strength in terms of innovation in business processes, leadership in customer value as well as market penetration. In short, the award looks at the emerging market players in the industry and recognizes their best practices that are positioned for future growth excellence.Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry. About GenePOC, Inc. Created in 2007 and located in Quebec city, Canada, GenePOC, Inc. is a privately owned company that develops rapid and cost-effective molecular tests to detect genes at Point of Care (POC). Since the PCR has been invented in the mid 80's, GenePOC founder, Dr. Michel G. Bergeron, had the goal of using DNA to speed up the identification of microbes to one hour or less instead of more than 48 hours with standard culture. For more information visit http://www.genepoc-diagnostics.com/Home.shtml GenePOC Contact: Dr. Patrice Allibert, Ph.D., CEO, P: +1 418 570 3611E: email@example.com www.genepoc-diagnostics.com About Frost & Sullivan Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV